1.
Risk Assessment of QT-Prolonging Drug Combinations and Their Association with QTc Interval Prolongation Among Psychiatric Patients: A Prospective Observational Study. Int. J. Res. Pharm. Sci. Technol. 2026;9(3). doi:10.33974/rveyrh87